Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Introduction to the Pharmaceutical Regulatory Process' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Pharmaceutical Regulatory Affairs in the EU and US | Dec 2006 | £1,095 | 100% |
| Cardiac Toxicity | Mar 2008 | £1,495 | 99% |
| The Pharmaceutical Excipients Market Outlook | Jan 2011 | £2,425 | 98% |
| South Korea: Healthcare System and Drug Regulatory Overview Healthcare |
Jul 2011 | £1,200 | 98% |
| Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry | May 2010 | £410 | 96% |
| A Practical Guide to Biopharmaceutical Manufacturing | Jan 2006 | £1,095 | 96% |
| Toxicology and Pharmacology Outsourcing, History, Process and Regulation; Technical, Political and Economic Challenges |
Jan 2010 | £595 | 96% |
| Nanostructured Materials for the Biomedical, Pharmaceutical, & Cosmetic Markets | Jan 2007 | £2,760 | 96% |
| Live-Licensing & In-life Testing R&D Processes and Regulation for New Drugs, 2008-2020 |
Jan 2008 | £1,499 | 96% |
| Biosimilars Evolution or Revolution |
Sep 2006 | £1,950 | 95% |
| Emerging Clinical Trial Locations - China Market Dynamics and The Changing Healthcare and Regulatory Environment |
Jun 2009 | £2,425 | 95% |
| Healthcare Industry Overview in Ethiopia | Jul 2010 | £4,745 | 94% |
| Clinical Trial Supply | Jan 2007 | £595 | 94% |
| Top 20 Contract Research Organizations (Cro) Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets |
Sep 2011 | £2,215 | 93% |
| Point of Care Testing Evaluating The Return to Evidence Based Medicine, Novel Technologies and The Competitive Landscape |
Jan 2010 | £2,425 | 93% |
| Pharmaceutical Pricing and Reimbursement in Europe Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies |
Nov 2011 | £2,215 | 93% |
| Business Intelligence in the Pharmaceutical Market Growth drivers, key organizational priorities, and vendor strategies for future growth |
May 2010 | £2,425 | 93% |
| Pharmacovigilance and Other Pharma Regulatory Developments 2011 - 2021 |
Aug 2011 | £1,499 | 92% |
| Contract Research and Manufacturing Services | Mar 2008 | £600 | 92% |
| Eprescribing Infrastructure and Impact on the Healthcare Markets in the US and EU |
Mar 2007 | £2,400 | 92% |
| Manufacturing of Solid Dosage Forms 2011 |
Feb 2011 | £2,215 | 92% |
| Top 10 Healthcare Trends in 2011 | Mar 2011 | £2,215 | 91% |
| Companion Biomarkers in Drug Development | Apr 2009 | £2,150 | 91% |
| Strategic Analysis of the Russian Pharmaceutical Market | Dec 2010 | £3,795 | 91% |
| Manufacturing of Biologics Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies |
Sep 2010 | £2,215 | 91% |
| GenericHandbook - Third Edition (2009) A Guide to the Generic Drug Industry in the US |
Apr 2009 | £475 | 91% |
| Sales Force Effectiveness in Pharmaceuticals Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies |
Oct 2010 | £2,215 | 91% |
| Outsourcing in Drug Development The Contract Research (Clinical Trial ) Market |
Jan 2012 | £2,525 | 91% |
| The Pharmaceutical Market: Norway | Oct 2011 | £595 | 90% |
| Pharmacovigilance and Related Developments 2011-2021 |
Aug 2011 | £1,499 | 90% |
